Endocrine and neuroendocrine tumours
Invited discussant abstracts 427PD and 428PD
Date
10 Oct 2016Session
Endocrine and neuroendocrine tumoursPresenters
Xavier Matias-GuiuAuthors
X. Matias-GuiuAuthor affiliations
- Anatomía Patológica, University of Lleida, Lleida/ES
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
2308 - Efficacy and safety of pasireotide LAR or everolimus alone, or in combination in patients with advanced carcinoids (NET) of the lung/thymus: Results from the randomized, phase 2 LUNA study
Presenter: Piero Ferolla
Session: Endocrine and neuroendocrine tumours
Resources:
Abstract
3485 - Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRIME-NET (Pancreatic multicentric, Retrospective, Italian MEtformin) study
Presenter: Sara Pusceddu
Session: Endocrine and neuroendocrine tumours
Resources:
Abstract
Invited discussant abstracts 416O and 417O
Presenter: James Yao
Session: Endocrine and neuroendocrine tumours
Resources:
Slides
Webcast
2668 - Pancreatic neuroendocrine tumour (pNET) profiles in the NETwork! programme: clinic–enabled genomics for genomic-enabled clinical decisions
Presenter: Ben Lawrence
Session: Endocrine and neuroendocrine tumours
Resources:
Abstract
Slides
3516 - Genomic profile in pulmonary neuroendocrine tumors (puNETs): the whole-exome sequencing (WES) as a strategic tool
Presenter: Ivana Sullivan
Session: Endocrine and neuroendocrine tumours
Resources:
Abstract
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.